MCKINLAY MARK 4

Accession 0001181431-04-020323

CIK 0000946840other

View on SEC.gov Company Profile

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 12:34 PM ET

Size

29.5 KB

Accession

0001181431-04-020323

Insider Transaction Report

Form 4

Period: 2004-04-12

VIROPHARMA INCVPHM

MCKINLAY MARK

VP Research & Development

Transactions

Award
Non-Qualified Stock Option (right to buy)
2004-04-12$3.93/sh+19,996$78,584→ 19,996 total
Exercise: $3.93From: 2004-04-12Exp: 2012-04-15→ Common Stock (19,996 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2004-04-12$2.09/sh−15,000$31,350→ 0 total
Exercise: $2.09From: 2004-04-12Exp: 2013-07-21→ Common Stock (15,000 underlying)
Award
Non-Qualified Stock Option (right to buy)
2004-04-12$2.09/sh+15,000$31,350→ 15,000 total
Exercise: $2.09From: 2004-04-12Exp: 2013-07-21→ Common Stock (15,000 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2004-04-12$3.93/sh−4$16→ 0 total
Exercise: $3.93From: 2004-04-12Exp: 2012-04-15→ Common Stock (4 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2004-04-12$0.99/sh−59,999$59,399→ 0 total
Exercise: $0.99From: 2004-04-12Exp: 2012-10-09→ Common Stock (59,999 underlying)
Award
Non-Qualified Stock Option (right to buy)
2004-04-12$0.99/sh+59,999$59,399→ 59,999 total
Exercise: $0.99From: 2004-04-12Exp: 2012-10-09→ Common Stock (59,999 underlying)
Award
Non-Qualified Stock Option (right to buy)
2004-04-12$0.99/sh+1$1→ 1 total
Exercise: $0.99From: 2004-04-12Exp: 2012-10-09→ Common Stock (1 underlying)
Award
Non-Qualified Stock Option (right to buy)
2004-04-12$3.93/sh+4$16→ 4 total
Exercise: $3.93From: 2004-04-12Exp: 2012-04-15→ Common Stock (4 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2004-04-12$3.93/sh−19,996$78,584→ 0 total
Exercise: $3.93From: 2004-04-12Exp: 2012-04-15→ Common Stock (19,996 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2004-04-12$2.09/sh−15,000$31,350→ 0 total
Exercise: $2.09From: 2004-04-12Exp: 2013-07-21→ Common Stock (15,000 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2004-04-12$0.99/sh−1$1→ 0 total
Exercise: $0.99From: 2004-04-12Exp: 2012-10-09→ Common Stock (1 underlying)

Footnotes (3)

[F1]Amendment of outstanding option resulting in deemed cancellation of option and re-grant of replacement option. The option was orginally granted on April 16, 2002 and was amended to extend the post-termination exercise period to one year following the achievement of a corporate goal and to change the vesting provision to vest the option in full upon the achievement of a corporate goal.
[F2]Amendment of outstanding option resulting in deemed cancellation of option and re-grant of replacement option. The option was orginally granted on October 10, 2002 and was amended to extend the post-termination exercise period to one year and to accelerate the vesting of the option.
[F3]Amendment of outstanding option resulting in deemed cancellation of option and re-grant of replacement option. The option was orginally granted on July 22, 2003 and was amended to extend the post-termination exercise period to one year and to accelerate the vesting of the option.

Documents

1 file

4
rrd39361.xmlPrimary
FORM 4

Issuer

VIROPHARMA INC

CIK 0000946840

→

Entity typeother

Related Parties

filerCIK 0001187161

Filing Metadata

Form type: 4
Filed: Apr 12, 8:00 PM ET
Accepted: Apr 13, 12:34 PM ET
Size: 29.5 KB

View on SEC.gov